Table of Contents
Table 5-51: Martin
Table 5-53: Monroe
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 76 | 437.2 | 478 | 560.8 | 34 | 200.9 | 191 | 227.4 |
| Esophagus | * | # | 8 | 9.0** | * | # | 8 | 8.9** |
| Stomach | * | # | 9 | 9.4** | * | # | 5 | 5.2** |
| Colon excluding Rectum | 8 | 44.8** | 38 | 47.3 | * | # | 19 | 24.0** |
| Rectum and Rectosigmoid Junction | 5 | 27.6** | 15 | 17.2** | * | # | 0 | # |
| Liver | * | # | 4 | # | * | # | 6 | 6.8** |
| Pancreas | * | # | 10 | 11.3** | * | # | 14 | 15.4** |
| Lung and Bronchus | 16 | 95.7** | 101 | 119.7 | 18 | 106.7** | 68 | 81.9 |
| Melanoma of the Skin | * | # | 16 | 21.2** | * | # | 0 | # |
| Prostate | 14 | 78.6** | 105 | 118.7 | * | # | 10 | 12.7** |
| Urinary Bladder | * | # | 38 | 46.6 | * | # | 5 | 6.3** |
| Kidney and Renal Pelvis | * | # | 19 | 21.9** | * | # | 4 | # |
| Brain and Other Nervous System | * | # | 8 | 9.0** | * | # | 5 | 5.3** |
| Non-Hodgkin Lymphoma | * | # | 10 | 11.9** | * | # | 9 | 10.7** |
| Myeloma | * | # | 7 | 8.0** | * | # | 4 | # |
| Leukemia | * | # | 13 | 14.8** | * | # | 6 | 7.0** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 78 | 386.9 | 432 | 426.7 | 40 | 192.6 | 204 | 193.6 |
| Colon excluding Rectum | 6 | 27.4** | 32 | 30.1 | * | # | 16 | 14.3** |
| Rectum and Rectosigmoid Junction | * | # | 10 | 9.4** | * | # | 2 | # |
| Liver | * | # | 5 | 4.9** | * | # | 6 | 5.8** |
| Pancreas | * | # | 11 | 10.4** | * | # | 11 | 9.9** |
| Lung and Bronchus | 18 | 82.8** | 81 | 78.0 | 14 | 66.9** | 59 | 57.0 |
| Melanoma of the Skin | * | # | 7 | 7.7** | * | # | 2 | # |
| Breast | 23 | 118.0 | 107 | 106.1 | 7 | 31.6** | 35 | 32.5 |
| Cervix Uteri | * | # | 5 | 5.4** | * | # | 1 | # |
| Corpus Uteri | * | # | 31 | 31.6 | * | # | 1 | # |
| Ovary | * | # | 13 | 13.2** | * | # | 8 | 8.3** |
| Urinary Bladder | * | # | 8 | 7.5** | * | # | 1 | # |
| Kidney and Renal Pelvis | 5 | 25.3** | 20 | 19.9 | * | # | 7 | 7.0** |
| Brain and Other Nervous System | * | # | 2 | # | * | # | 2 | # |
| Non-Hodgkin Lymphoma | * | # | 22 | 20.5 | * | # | 10 | 9.1** |
| Myeloma | * | # | 3 | # | * | # | 2 | # |
| Leukemia | * | # | 10 | 10.3** | * | # | 5 | 5.2** |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, June 2007
Table of Contents
Table 5-51: Martin
Table 5-53: Monroe
